For instance, cancer cells are frequently characterized by altered expression of various components of the IGF including autocrine and/or paracrine secretion of IGFs (IGF-I and IGF-II) and overexpression of their cognate receptors [the IGF-I receptor, IGF-insulin receptor (IR), and the closely related IR]. This evidence concerns the gene IGF2 and cancer.